Related Experiment Videos
CA9 expression as a prognostic factor in renal clear cell carcinoma
Bülent Soyupak1, Seyda Erdoğan, Melek Ergin
1Department of Urology, Cukurova University Medical Faculty, Adana, Turkey. bsoyupak@cu.edu.tr
Urologia Internationalis
|February 16, 2005
Summary
Carbonic anhydrase 9 (CA9) protein shows promise as a diagnostic and prognostic marker for clear cell renal cell carcinoma. High CA9 expression indicates better survival, while low expression is linked to poorer outcomes.
Area of Science:
- Oncology
- Biomarker Discovery
- Renal Cell Carcinoma Research
Background:
- Investigating the role of Carbonic Anhydrase 9 (CA9) protein in renal clear cell carcinoma.
- Assessing CA9 as both a diagnostic and prognostic tumor marker.
Purpose of the Study:
- To determine the utility of CA9 protein as a prognostic marker in renal clear cell carcinoma.
- To evaluate CA9 as a diagnostic biomarker for this cancer type.
Main Methods:
- Immunohistochemical analysis of CA9 protein expression on 92 nephrectomy specimens.
- Correlation of CA9 staining with tumor stage, grade, metastasis, and patient survival.
- Inclusion of 67 clear cell renal cell carcinomas, 10 adenomas, and 2 oncocytomas.
Main Results:
- CA9 protein was detected in 91.2% of clear cell renal cell carcinomas.
- Low CA9 expression was identified as a poor prognostic factor, while high expression was a good prognostic indicator.
- CA9 expression proved to be the most significant prognostic factor compared to tumor stage and grade.
Conclusions:
- CA9 is a significant molecular marker for renal clear cell carcinomas.
- Decreased CA9 expression is independently associated with poor patient survival.
- CA9 can predict clinical outcomes and identify high-risk patients for targeted therapies and immunotherapy.